Differentiation potential of urothelium from patients with benign bladder dysfunction.
about
Evidence for bladder urothelial pathophysiology in functional bladder disordersPathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of DiseaseStructure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives.ATP during early bladder stretch is important for urgency in detrusor overactivity patientsImmunocytochemical characterisation of cultures of human bladder mucosal cellsA mouse model for interstitial cystitis/painful bladder syndrome based on APF inhibition of bladder epithelial repair: a pilot studyIncreased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease.Aquaporin expression contributes to human transurothelial permeability in vitro and is modulated by NaCl.Differentiation-associated reprogramming of the transforming growth factor β receptor pathway establishes the circuitry for epithelial autocrine/paracrine repairKrüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 ExpressionThe human urothelial tight junction: claudin 3 and the ZO-1α(+) switch.Increased bladder permeability in interstitial cystitis/painful bladder syndrome.Do mesenchymal stem cells modulate the milieu of reconstructed bladder wall?An examination of regenerative medicine-based strategies for the urinary bladder.Botulinum toxin injection for lower urinary tract dysfunction.FOXA1 and IRF-1 intermediary transcriptional regulators of PPARgamma-induced urothelial cytodifferentiation.Abnormal Akt signalling in bladder epithelial cell explants from patients with interstitial cystitis/bladder pain syndrome can be induced by antiproliferative factor treatment of normal bladder cells.Nerve hyperplasia: a unique feature of ketamine cystitis.Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cellsEvaluation of gene expression changes in human primary uroepithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites.Primary cultures of human urothelial cells for genotoxicity testing.Differentiation-associated urothelial cytochrome P450 oxidoreductase predicates the xenobiotic-metabolizing activity of "luminal" muscle-invasive bladder cancers.Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study.Perilla extract improves frequent urination in spontaneously hypertensive rats with enhancement of the urothelial presence and anti-inflammatory effects.
P2860
Q26824708-6C126D4B-1D5C-4299-AAA5-DA18A257CABBQ28079052-D000E671-7A65-457D-AC88-DC66A7228D4AQ33558063-D79C1444-54BE-4CAE-829D-511D9BF56C3BQ33757819-B86CD57E-B06A-46E6-A4DB-3F912F085552Q33874538-338E4C02-2737-4FD9-84C9-B4903310A317Q34298261-0EE859C4-514F-4191-A0A3-9371A4E08390Q34427251-39C95AD4-F76A-4DBB-903A-A4D9819E1E59Q34428811-8020A404-D266-47DB-92D2-730C5017AC76Q34531854-544CDB21-8819-46A5-B21B-D56ACB647E98Q35861040-C517366E-FAA3-45BF-AA34-35A4C99550B9Q35933212-D881664A-D389-4043-956C-EE27B5598A36Q36445359-95F4FBAD-5106-4966-ABA5-11B10C307657Q37501897-9DE894D6-2833-47B0-81D3-3C40EB3BA6ADQ37931910-A72D0484-D418-4BBC-AB44-85A89F5263E4Q38008697-4B9FD34B-926B-4E47-B040-4416E14088FDQ38288442-10C59FB7-1AAF-4CCB-9801-064583106A63Q40776023-8C7B98E8-BA63-4749-BC4B-7011D199B688Q41874803-11D10FC8-2B90-4D99-94FF-11C22C155753Q42315527-DB9C4AEE-E379-4690-AFE9-94EFC64D2B9AQ42714046-998FDEAF-0730-47F4-960A-BDBA985DBDD4Q46527366-3F2D2A42-D1C7-4E0D-8C66-3F1A2F2980B5Q48261416-A8AF49E3-0DC8-41B1-B1A8-C60BBD3F6129Q48439311-B7712132-1B18-4D5B-8644-83FC84D94001Q52738809-FCF5C625-118A-40E0-952E-969F32651009
P2860
Differentiation potential of urothelium from patients with benign bladder dysfunction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Differentiation potential of urothelium from patients with benign bladder dysfunction.
@ast
Differentiation potential of urothelium from patients with benign bladder dysfunction.
@en
type
label
Differentiation potential of urothelium from patients with benign bladder dysfunction.
@ast
Differentiation potential of urothelium from patients with benign bladder dysfunction.
@en
prefLabel
Differentiation potential of urothelium from patients with benign bladder dysfunction.
@ast
Differentiation potential of urothelium from patients with benign bladder dysfunction.
@en
P2093
P2860
P1433
P1476
Differentiation potential of urothelium from patients with benign bladder dysfunction.
@en
P2093
Claire L Varley
Fiona Marsh
Ian Eardley
Jennifer Hinley
Jens Stahlschmidt
Ludwik K Trejdosiewicz
Mary A E Garthwaite
P2860
P304
P356
10.1111/J.1464-410X.2007.06795.X
P577
2007-06-01T00:00:00Z